TH

Thore Hettmann

DG Daiichi Sankyo Europe Gmbh: 6 patents #1 of 25Top 4%
AM Amgen: 4 patents #785 of 2,867Top 30%
UG U3 Pharma Gmbh: 3 patents #3 of 25Top 15%
DL Daiichi Sankyo Company, Limited: 2 patents #287 of 842Top 35%
VN Vivoryon Therapeutics N.V.: 1 patents #6 of 14Top 45%
Overall (All Time): #444,024 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12139549 Material and methods for treating or preventing HER-3 associated diseases Daniel J. Freeman, Robert Radinsky 2024-11-12
12043659 Humanized and de-immunized antibodies Jens-Ulrich Rahfeld, Stephen D. Gillies, Stephan Schilling, Martin Kleinschmidt 2024-07-23
11351259 HER3 inhibitor for modulating radiosensitivity Deric L. Wheeler 2022-06-07
11298359 Anti-HER3 antibody-drug conjugate Reimar Abraham, Sabine BLUM, Suguru UENO 2022-04-12
10383878 Anti-HER3 antibody-drug conjugate Reimar Abraham, Sabine BLUM, Suguru UENO 2019-08-20
10357566 HER3 inhibitor for modulating radiosensitivity Deric L. Wheeler 2019-07-23
9988462 Material and methods for treating or preventing HER-3 associated diseases Daniel J. Freeman, Robert Radinsky, Mike Rothe 2018-06-05
9803025 Material and methods for treating or preventing HER-3 associated diseases Daniel J. Freeman, Robert Radinsky 2017-10-31
9101760 Material and methods for treating or preventing HER-3 associated diseases Daniel J. Freeman, Robert Radinsky 2015-08-11
8933202 AXL antibodies Jens Niewöhner, Jens Ruhe, Peter Wirtz, Kerstin SELLE, Esther Zwick-Wallasch +1 more 2015-01-13
8828382 Heparin-binding epidermal growth factor-like growth factor binding proteins Mike Rothe, Norbert Prenzel, Eric Borges, Esther Zwick-Wallasch, Orit Foord 2014-09-09